- Home
- WAVE vs ANTX Comparison
WAVE vs ANTX Comparison
Compare WAVE & ANTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WAVE
- ANTX
- Stock Information
- Founded
- WAVE 2011
- ANTX 2017
- Country
- WAVE Israel
- ANTX United States
- Employees
- WAVE N/A
- ANTX N/A
- Industry
- WAVE Electric Utilities: Central
- ANTX Biotechnology: Pharmaceutical Preparations
- Sector
- WAVE Utilities
- ANTX Health Care
- Exchange
- WAVE Nasdaq
- ANTX Nasdaq
- Market Cap
- WAVE 27.0M
- ANTX 33.2M
- IPO Year
- WAVE 2021
- ANTX 2022
- Fundamental
- Price
- WAVE $6.67
- ANTX $1.07
- Analyst Decision
- WAVE Strong Buy
- ANTX Buy
- Analyst Count
- WAVE 1
- ANTX 2
- Target Price
- WAVE $15.00
- ANTX $2.00
- AVG Volume (30 Days)
- WAVE 20.1K
- ANTX 287.9K
- Earning Date
- WAVE 08-28-2025
- ANTX 08-12-2025
- Dividend Yield
- WAVE N/A
- ANTX N/A
- EPS Growth
- WAVE N/A
- ANTX N/A
- EPS
- WAVE N/A
- ANTX N/A
- Revenue
- WAVE $168,000.00
- ANTX N/A
- Revenue This Year
- WAVE $325.00
- ANTX N/A
- Revenue Next Year
- WAVE $85.71
- ANTX N/A
- P/E Ratio
- WAVE N/A
- ANTX N/A
- Revenue Growth
- WAVE N/A
- ANTX N/A
- 52 Week Low
- WAVE $2.39
- ANTX $0.87
- 52 Week High
- WAVE $17.63
- ANTX $3.07
- Technical
- Relative Strength Index (RSI)
- WAVE 57.78
- ANTX 42.84
- Support Level
- WAVE $6.61
- ANTX $1.07
- Resistance Level
- WAVE $6.85
- ANTX $1.11
- Average True Range (ATR)
- WAVE 0.41
- ANTX 0.04
- MACD
- WAVE 0.10
- ANTX 0.00
- Stochastic Oscillator
- WAVE 83.81
- ANTX 7.14
About WAVE Eco Wave Power Global AB (publ)
Eco Wave Power Global AB is a Sweden-based wave energy company engaged in the development of a smart and cost-efficient WEC, technology that converts ocean and sea waves into clean electricity. Its WEC technology employs units of point absorber floating devices, referred to as floaters, which are installed on existing marine structures such as piers, breakwaters, and jetties, or in locations in which such marine structures are required. Geographical presence in Israel, USA and Mexico.
About ANTX AN2 Therapeutics Inc.
AN2 Therapeutics Inc is a biopharmaceutical company focused on discovering and developing novel small molecule therapeutics derived from its boron chemistry platform. The company has a pipeline of boron-based compounds in development for Chagas disease, non-tuberculous mycobacterial (NTM) and melioidosis, along with early-stage programs focused on targets in infectious diseases and oncology.